• 1-800-526-8630U.S. (TOLL FREE)
  • 1-917-300-0470EAST COAST U.S.
  • +353-1-416-8900REST OF WORLD

PRODUCT FILTERS

REGION

1,010
83
63
60
46

COUNTRY

58
19
10
7
5

CATEGORIES

  • 85
  • 124
  • 66
  • 65
  • 37
  • 37
  • 12
  • 12
  • 11
  • 18

PRICE

143
607
1,009
2,730

PUBLISHED

7
75
620
2,730

PRODUCT TYPE

2,619
91
12
7
1

Oncology

(2,730 Products)

The American Cancer Society forecasts that 1,638,910 new cancer cases will occur in the United States in 2012. As cancer rates worldwide are increasing, the oncological sector of the pharmaceutical industry is growing fast and it will continue to provide business opportunities in the next years. However, cancer trials are some of the most complex, time consuming and expensive across all therapeutic areas. What are the new paths to success in this lucrative but challenging market?

Find out the answer in the reports, books, and subscriptions listed under Research and Markets’ Oncology category. Our top-quality publications from industry experts cover every aspect of cancer drug therapy, with a focus on: Lung Cancer, Breast Cancer, Prostate Cancer, Leukaemia, Lymphoma, Ovarian Cancer, Colon Cancer, Cervical Cancer, Brain Cancer and Bladder Cancer. So read on for the latest clinical trials, pipeline reviews, industry news, and commercial opportunities.

Key players featured in our publications include Abbott, AstraZeneca, Bristol-Myers Squibb, Eli Lilly, GlaxoSmithKline, Johnson & Johnson, Merck, Novartis, Pfizer, Roche, Sanofi-Aventis, Wyeth, and many more. Show Less
Read more

PRODUCT TITLE

Cervical Cancer Treatment Drugs Markets in China

China's demand for Cervical Cancer Treatment Drugs has grown at a fast pace in the past decade. In the next five years, both production and demand will continue to grow. This new study examines China's...

June 2014
FROM

Breast Cancer Treatment Drug Markets in China

China's demand for Breast Cancer Treatment Drug has grown at a fast pace in the past decade. In the next five years, both production and demand will continue to grow. This new study examines China's...

June 2014
FROM

Cancer Cytokines Therapy Pipeline Analysis

Cytokines, a major group in the protein therapeutics umbrella, are known to be soluble extracellular proteins or glycoproteins which are crucial intercellular regulators, having the capacity to mobilize...

June 2014
FROM

Kidney Cancer Treatment Drugs Markets in China

China's demand for Kidney Cancer Treatment Drugs has grown at a fast pace in the past decade. In the next five years, both production and demand will continue to grow. This new study examines China's...

June 2014
FROM

Cervical Cancer Drug Market & Pipeline Insight

Cervical cancer is the third and fourth most common cause of cancer incidence and mortality among women across the world. Though there has been a decline in cervical cancer mortality rates in the previous...

June 2014
FROM

Breast Cancer Therapeutics in Major Developed Markets to 2020 - Approval of Novel Therapies to Support Continued Dominance of HER2 Targeted Drugs

The leading business intelligence provider, has released its latest research, '‘Breast Cancer Therapeutics in Major Developed Markets to 2020 - Approval of Novel Therapies to Support Continued Dominance...

June 2014
FROM

Gastric Cancer - Pipeline Review, H1 2014

Gastric Cancer - Pipeline Review, H1 2014 Summary Global Markets Direct’s, ‘Gastric Cancer - Pipeline Review, H1 2014’, provides an overview of the Gastric Cancer’s therapeutic pipeline. This report...

May 2014
FROM

Chemotherapy Induced Myelosuppression - Pipeline Review, H1 2014

Chemotherapy Induced Myelosuppression - Pipeline Review, H1 2014 Summary Global Markets Direct’s, ‘Chemotherapy Induced Myelosuppression - Pipeline Review, H1 2014’, provides an overview of the Chemotherapy...

May 2014
FROM

Colorectal Cancer - Pipeline Review, H1 2014

Colorectal Cancer - Pipeline Review, H1 2014 Summary Global Markets Direct’s, ‘Colorectal Cancer - Pipeline Review, H1 2014’, provides an overview of the Colorectal Cancer’s therapeutic pipeline. This...

May 2014
FROM

Relapsed Acute Myeloid Leukemia - Pipeline Review, H1 2014

Relapsed Acute Myeloid Leukemia - Pipeline Review, H1 2014 Summary Global Markets Direct’s, ‘Relapsed Acute Myeloid Leukemia - Pipeline Review, H1 2014’, provides an overview of the Relapsed Acute...

May 2014
FROM

Hepatocellular Carcinoma - Pipeline Review, H1 2014

Hepatocellular Carcinoma - Pipeline Review, H1 2014 Summary Global Markets Direct’s, ‘Hepatocellular Carcinoma - Pipeline Review, H1 2014’, provides an overview of the Hepatocellular Carcinoma’s therapeutic...

May 2014
FROM

Refractory Leukemia - Pipeline Review, H1 2014

Refractory Leukemia - Pipeline Review, H1 2014 Summary Global Markets Direct’s, ‘Refractory Leukemia - Pipeline Review, H1 2014’, provides an overview of the Refractory Leukemia’s therapeutic pipeline. This...

May 2014
FROM

Adrenocortical Carcinoma (Adrenal Cortex Cancer) - Pipeline Review, H1 2014

Adrenocortical Carcinoma (Adrenal Cortex Cancer) - Pipeline Review, H1 2014 Summary Global Markets Direct’s, ‘Adrenocortical Carcinoma (Adrenal Cortex Cancer) - Pipeline Review, H1 2014’, provides...

May 2014
FROM

Metastatic Uveal Melanoma - Pipeline Review, H1 2014

Metastatic Uveal Melanoma - Pipeline Review, H1 2014 Summary Global Markets Direct’s, ‘Metastatic Uveal Melanoma - Pipeline Review, H1 2014’, provides an overview of the Metastatic Uveal Melanoma’s...

May 2014
FROM

Refractory Acute Myeloid Leukemia - Pipeline Review, H1 2014

Refractory Acute Myeloid Leukemia - Pipeline Review, H1 2014 Summary Global Markets Direct’s, ‘Refractory Acute Myeloid Leukemia - Pipeline Review, H1 2014’, provides an overview of the Refractory...

May 2014
FROM

Deals in Oncology Personalized Medicine Industry – Worldwide Analysis

The Personalized Medicine in Oncology Deals and Alliances of 2014 report provides comprehensive understanding and unprecedented access to the partnering deals and agreements entered into by the world’s...

May 2014
FROM

Squamous Cell Carcinoma Global Clinical Trials Review, H1, 2014

Squamous Cell Carcinoma Global Clinical Trials Review, H1, 2014 Summary Our clinical trial report, “Squamous Cell Carcinoma Global Clinical Trials Review, H1, 2014" provides data on the Squamous Cell...

May 2014
FROM

Relapsed Multiple Myeloma Global Clinical Trials Review, H1, 2014

Relapsed Multiple Myeloma Global Clinical Trials Review, H1, 2014 Summary Our clinical trial report, “Relapsed Multiple Myeloma Global Clinical Trials Review, H1, 2014" provides data on the Relapsed...

May 2014
FROM

Squamous Non-Small Cell Lung Cancer Global Clinical Trials Review, H1, 2014

Squamous Non-Small Cell Lung Cancer Global Clinical Trials Review, H1, 2014 Summary Our clinical trial report, “Squamous Non-Small Cell Lung Cancer Global Clinical Trials Review, H1, 2014" provides...

May 2014
FROM

Skin Cancer Global Clinical Trials Review, H1, 2014

Skin Cancer Global Clinical Trials Review, H1, 2014 Summary Our clinical trial report, “Skin Cancer Global Clinical Trials Review, H1, 2014" provides data on the Skin Cancer clinical trial scenario....

May 2014
FROM
Loading Indicator

Our Clients

Photocure ASA Roche Diagnostics Ltd. Abbott Laboratories Ltd. Pfizer, Inc. Novartis AG Becton, Dickinson and Company (BD)